BEYOND AIR INC. - COMMON STOCK

Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022

25 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

Beyond Air® to Participate in Three Upcoming Medical Conferences

18 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect

11 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting

08 Mar 2022 16:35:00 By Nasdaq GlobeNewswire

Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022

10 Feb 2022 16:05:01 By Nasdaq GlobeNewswire

Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022

08 Feb 2022 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® Announces Two Appointments to Beyond Cancer™ Board of Directors

03 Feb 2022 16:05:00 By Nasdaq GlobeNewswire

Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and Webcast

27 Jan 2022 08:00:03 By Nasdaq GlobeNewswire

Beyond Air® Provides Regulatory Update for LungFit® PH

09 Dec 2021 08:30:00 By Nasdaq GlobeNewswire

Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer

01 Dec 2021 08:00:02 By Nasdaq GlobeNewswire

Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer™ Private Placement

18 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2022

11 Nov 2021 16:05:01 By Nasdaq GlobeNewswire

Beyond Air® Announces Formation of Beyond Cancer™, a New Private Company Dedicated to Oncology Utilizing Ultra-High Concentration Nitric Oxide to Treat Solid Tumors

04 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Beyond Air® to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

02 Nov 2021 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® Schedules Second Fiscal Quarter 2022 Financial Results Conference Call and Webcast

25 Oct 2021 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® Reports Positive Interim Results for LungFit® GO Pilot Study Using High Concentration Inhaled Nitric Oxide Self-Administered, At-Home for Nontuberculous Mycobacterial Lung Disease

20 Oct 2021 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® Provides Global Regulatory Update for LungFit® PH

21 Sep 2021 16:30:00 By Nasdaq GlobeNewswire

Beyond Air® to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

14 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Beyond Air® Announces CFO Transition

20 Aug 2021 16:15:00 By Nasdaq GlobeNewswire

Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2022

10 Aug 2021 16:05:01 By Nasdaq GlobeNewswire